Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;96(8):1236-8.
doi: 10.3324/haematol.2011.047803.

Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms

Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms

Chiara Elena et al. Haematologica. 2011 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Dynamics of telomere shortening in patients with myeloproliferative neoplasm (MPN) and in healthy subjects. (A) In healthy controls Spearman’s rank test revealed a significant negative linear correlation between telomere fluorescence, expressed as Molecular Equivalent of Soluble Fluorescence (MESF), and age both in peripheral blood (PB) granulocytes and lymphocytes (P<0.001). In contrast, in MPN patients this relationship was present in PB lymphocytes (P<0.001) but not in granulocytes (P=0.40). (B) Age-corrected telomere length (DeltaTELgran) is significantly shorter in MPN patients (median value −11.14, range −23.99 to 9.78) than in healthy individuals (−0.05, −4.74 to 5.75; Kolmogorov-Smirnov’s test P<0.001).

References

    1. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009;361(24):2353–65. - PMC - PubMed
    1. Ferraris AM, Pujic N, Mangerini R, Rapezzi D, Gallamini A, Racchi O, et al. Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres. Br J Haematol. 2005;130(3):391–3. - PubMed
    1. Terasaki Y, Okumura H, Ohtake S, Nakao S. Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases. Exp Hematol. 2002;30(12):1399–404. - PubMed
    1. Spanoudakis E, Bazdiara I, Pantelidou D, Kotsianidis I, Papadopoulos V, Margaritis D, et al. Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms. Leuk Res. 2011;35(4):459–64. - PubMed
    1. Bernard L, Belisle C, Mollica L, Provost S, Roy DC, Gilliland DG, et al. Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms. Leukemia. 2009;23(2):287–91. - PMC - PubMed

Publication types